VivoSeq
Musculoskeletal

Lumbar Erector Spinae Plane Block

0

Pipeline Programs↗

0

Active Trials↗

0

Companies Involved↗

Lumbar Erector Spinae Plane Block is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

75/100

Attrition Rate

20/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

5

clinical trials

Completed3 · 60%
Terminated1 · 20%
Unknown status1 · 20%

Clinical Trials

Trial Activity

Combined Lumbar Erector Spinae Plane Block and Pericapsular Nerve Group Block in Patients Undergoing Hip Surgeries
Completed·MMenoufia University·Phase 4·NCT05930171·24 enrolled
The Use of Lumbar Erector Spinae Plane Block for Hip Arthroplasty at the L4 Interspace
Terminated·MMontefiore Medical Center·N/A·NCT03801863·65 enrolled
Lumbar Erector Spinae Plane Block for Back Surgery
Unknown status·DDr M. B. Breebaart·Phase 3·NCT03825198·80 enrolled
Pericapsular Nerve Group (PENG) Block Versus Lumbar Erector Spinae Plane Block
Completed·ZZagazig University·Phase 2·NCT04899388·69 enrolled
Efficacy of Surgical Injection Lumbar Erector Spinae Plane Block
Completed·—·N/A·NCT05630404·90 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)